Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223079 · ClinicalTrials.gov registry record · NA
Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01223079: Completed NA study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT01223079 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01223079, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the safety and efficacy of r-hLH to r-hFSH in the late follicular phase of young women undergoing controlled ovarian stimulation for oocyte donation.
Primary Outcome
Evaluation of the safety and efficacy of r-hFSH for controlled ovarian stimulation in the same patients.
Interventions
- DRUG r-hFSH
- DRUG r-hFSH and r-hLH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT01223079 record still lists
NCT01223079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which r-hFSH is the first listed.
NCT01223079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01223079 about?
NCT01223079 is a clinical study titled "Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)". The purpose of the study is to compare the safety and efficacy of r-hLH to r-hFSH in the late follicular phase of young women undergoing controlled ovarian stimulation for oocyte donation.
What is the current status of trial NCT01223079?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2005-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT01223079?
The interventions under investigation include: r-hFSH (DRUG), r-hFSH and r-hLH (DRUG).
Who is sponsoring clinical trial NCT01223079?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01223079's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia